Why Eton Pharmaceuticals Is Top of the Class Today
Eton's cure for an expensive valuation: a 99% sales growth rate.
Overview
Eton Pharmaceuticals (NASDAQ: ETON) stock soared 41.9% through 2:15 p.m. ET Friday after beating analyst forecasts for Q2 with a stick.
Heading into the report, Wall Street had Eton pegged for a $0.15 per share profit on just $26.9 million in sales. Instead, the developer of drugs for rare diseases announced a profit of $0.43 per share -- and $37.6 million in sales.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.